Use of neostigmine in capecitabine-induced paralytic ileus

Gabriel Mak; Robyn L Ward; Yahya Shehabi; Ramya Venkateswaran; Melvin T. M. Chin

doi:10.1700/1377.15320

Use of neostigmine in capecitabine-induced paralytic ileus

Gabriel Mak, Robyn L Ward, Yahya Shehabi, Ramya Venkateswaran, Melvin T. M. Chin

Research output: Contribution to journal › Article › Research › peer-review

2 Citations (Scopus)

Abstract

Paralytic ileus is a recognised side effect of the oral agent capecitabine. We present this report on a patient with metastatic colorectal cancer who was treated with capecitabine and presented with persistent paralytic ileus which did not respond to standard conservative measures. Neostigmine was administered safely, resulting in resolution of the paralytic ileus. This approach merits further investigation.

Original language	English
Pages (from-to)	e225-e228
Number of pages	4
Journal	Tumori
Volume	99
Issue number	5
DOIs	https://doi.org/10.1700/1377.15320
Publication status	Published - Sept 2013
Externally published	Yes

Keywords

Capecitabine
Neostigmine
Paralytic ileus

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1700/1377.15320

Cite this

@article{1bf574b781604e409c3843a66dfe6f60,

title = "Use of neostigmine in capecitabine-induced paralytic ileus",

abstract = "Paralytic ileus is a recognised side effect of the oral agent capecitabine. We present this report on a patient with metastatic colorectal cancer who was treated with capecitabine and presented with persistent paralytic ileus which did not respond to standard conservative measures. Neostigmine was administered safely, resulting in resolution of the paralytic ileus. This approach merits further investigation.",

keywords = "Capecitabine, Neostigmine, Paralytic ileus",

author = "Gabriel Mak and Ward, {Robyn L} and Yahya Shehabi and Ramya Venkateswaran and Chin, {Melvin T. M.}",

year = "2013",

month = sep,

doi = "10.1700/1377.15320",

language = "English",

volume = "99",

pages = "e225--e228",

journal = "Tumori",

issn = "0300-8916",

publisher = "SAGE Publications Ltd",

number = "5",

}

TY - JOUR

T1 - Use of neostigmine in capecitabine-induced paralytic ileus

AU - Mak, Gabriel

AU - Ward, Robyn L

AU - Shehabi, Yahya

AU - Venkateswaran, Ramya

AU - Chin, Melvin T. M.

PY - 2013/9

Y1 - 2013/9

N2 - Paralytic ileus is a recognised side effect of the oral agent capecitabine. We present this report on a patient with metastatic colorectal cancer who was treated with capecitabine and presented with persistent paralytic ileus which did not respond to standard conservative measures. Neostigmine was administered safely, resulting in resolution of the paralytic ileus. This approach merits further investigation.

AB - Paralytic ileus is a recognised side effect of the oral agent capecitabine. We present this report on a patient with metastatic colorectal cancer who was treated with capecitabine and presented with persistent paralytic ileus which did not respond to standard conservative measures. Neostigmine was administered safely, resulting in resolution of the paralytic ileus. This approach merits further investigation.

KW - Capecitabine

KW - Neostigmine

KW - Paralytic ileus

UR - http://www.scopus.com/inward/record.url?scp=84893499726&partnerID=8YFLogxK

U2 - 10.1700/1377.15320

DO - 10.1700/1377.15320

M3 - Article

C2 - 24362874

AN - SCOPUS:84893499726

SN - 0300-8916

VL - 99

SP - e225-e228

JO - Tumori

JF - Tumori

IS - 5

ER -

Use of neostigmine in capecitabine-induced paralytic ileus

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Cite this